“Nudges” from electronic health records could improve the implementation of tobacco use treatment almost three-fold over standard care.

CHOP has treated its 500th patient with CAR T-cell immunotherapy, a “living drug” that harnesses the power of a patient’s own immune system to fight cancer.

CHOP researchers have shown that NSAIDs disrupt epithelial cells in the colon and sensitize them to C. difficile toxins by perturbing cell mitochondria.

Children’s Hospital of Philadelphia (CHOP) has been recognized by the 2023 Disability Equality Index (DEI) as a leader in “Best Places to Work for Disability Inclusion.”

The Neurologic Infections Clinic at Children’s Hospital of Philadelphia (CHOP) was established to enhance clinical care for children with definite or suspected, acute and chronic, standard and emerging infections of the central nervous system. We combine pediatric neurology and pediatric infectious diseases expertise to optimize multidisciplinary evaluation, acute care and long-term management of these children. 

Agenesis of the corpus callosum (ACC) is one of the most common referrals seen in the prenatal period at the Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment (CFDT) at Children’s Hospital of Philadelphia (CHOP). 

Christopher Cielo, DO, joined the Division of Pulmonary and Sleep Medicine at Children’s Hospital of Philadelphia (CHOP) in 2010 and is an attending pulmonologist.

CHOP researchers suggest more targeted intervention against discrimination, particularly in states with higher rates of structural stigma.

Dr. Lori Handy talks about pneumococcal infections in kids, the complications that can result in hospitalization, and why pneumococcal vaccines were more difficult to make than some other vaccine-preventable bacterial infections.

Watch "Marion Gruber: Preparedness Is Prevention," a film that showcases Dr. Gruber’s years working as a scientist at the FDA.